Department of Pharmacology and Experimental Therapeutics, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Adv Exp Med Biol. 2011;716:143-59. doi: 10.1007/978-1-4419-9533-9_9.
The multiple cell types that comprise the immune system provide an efficient defense system against invading pathogens and micro-organisms. In general, immune cells are activated for disparate functions, such as proliferation, production and release of mediators and chemotaxis, as a result of interactions between ligands and their matching immunoreceptors. This in turn leads to the recruitment and activation of a cascade of second messengers, via their regulators/adaptors, that determine the net effect of the initial response. However, activation of cells of the immune system must be tightly regulated by a finely tuned interplay between activation and inhibition to avoid excessive or inappropriate responsiveness and to maintain homeostasis. Loss of inhibitory signals may disrupt this balance, leading to various pathological processes such as allergic and auto-immune diseases. In this chapter, we will discuss down-regulating mechanisms of mast cells focusing on immunoreceptor tyrosine-based inhibition motifs (ITIM)-containing inhibitory receptors (IR).
免疫系统由多种细胞类型组成,为抵御入侵的病原体和微生物提供了有效的防御系统。一般来说,免疫细胞的激活具有不同的功能,如增殖、产生和释放介质以及趋化作用,这是配体与其匹配的免疫受体相互作用的结果。这反过来又导致通过其调节剂/衔接蛋白招募和激活一连串的第二信使,从而确定初始反应的净效应。然而,免疫系统细胞的激活必须通过激活和抑制之间的精细相互作用来严格调节,以避免过度或不适当的反应,并维持体内平衡。抑制信号的丧失可能会破坏这种平衡,导致各种病理过程,如过敏和自身免疫性疾病。在本章中,我们将讨论专注于含免疫受体酪氨酸基抑制基序(ITIM)的抑制性受体(IR)的肥大细胞的下调机制。